Pancreatic Cancer Research

ResearcherKaohsiung Medical UniversityActive in the last 2 years

Wan-Chi Tsai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5110481732. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Bioengineered extracellular vesicles integrating anti-EphA2 recognition and oxaliplatin delivery for pancreatic cancer therapy. First author DOI 10.1080/10717544.2026.2728215↗
  2. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. Co-author DOI 10.18632/oncotarget.16450↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi-Wei Chao · 1 shared paper, 2026 · strength 0.27
  2. Chih-Hung Chuang · 1 shared paper, 2026 · strength 0.27
  3. Yi-Jin Chen · 1 shared paper, 2017 · strength 0.08
  4. Po‐Chen Chu · 1 shared paper, 2017 · strength 0.08
  5. Jing‐Ru Weng · 1 shared paper, 2017 · strength 0.08
  6. Li‐Yuan Bai · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.